Human Molecular Genetics, 2003, Vol. 12, No. 1 1-12
© 2003 Oxford University Press
Cell death triggered by polyglutamine-expanded huntingtin in a neuronal cell line is associated with degradation of CREB-binding protein
1Department of Pharmacology and 2Department of Neuroscience, University of Pittsburgh School of Medicine, Pittsburgh, PA 15261, USA and 3Laboratory of Molecular Neurobiology, Department of Psychiatry and Neuroscience, The Program in Cellular and Molecular Medicine, The Johns Hopkins University School of Medicine Baltimore, MD 21205, USA
Received July 10, 2002; Revised October 10, 2002; Accepted October 30, 2002
Huntington's Disease belongs to the CAG repeat family of neurodegenerative diseases and is characterized by the presence of an expanded polyglutamine (polyQ) repeat in the huntingtin (htt) gene product. PolyQ-expanded htt accumulates within large aggregates that are found in various subcellular compartments, but are more often localized within the nucleus. It has been suggested that the sequestration of proteins essential to cell viability may be one mechanism that accounts for toxicity generated by polyQ-expanded proteins. Nuclear inclusions containing polyQ-expanded htt recruit the transcriptional cofactor, CREB-binding protein (CBP). PolyQ toxicity appears to involve alterations of gene transcription and reduced neuronal cell viability. In the HT22 hippocampal cell line, we find that toxicity within individual cells induced by polyQ-expanded htt, as revealed by a TUNEL assay, is associated with the localization of the mutant htt within either nuclear or perinuclear aggregates. However, in addition to CBP recruitment, we show here that CBP ubiquitylation and degradation can be selectively enhanced by polyQ-expanded htt. Thus, selected substrates may be directed to the ubiquitin/proteasome-dependent protein degradation pathway in response to polyQ-expanded htt within the nucleus.
* To whom correspondence should be addressed. Tel: +1 4126244259; Fax: +1 4126481945; Email: dod1{at}pitt.edu
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
B. Mellstrom, M. Savignac, R. Gomez-Villafuertes, and J. R. Naranjo Ca2+-Operated Transcriptional Networks: Molecular Mechanisms and In Vivo Models Physiol Rev, April 1, 2008; 88(2): 421 - 449. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Lim, L. Fedrizzi, M. Tartari, C. Zuccato, E. Cattaneo, M. Brini, and E. Carafoli Calcium Homeostasis and Mitochondrial Dysfunction in Striatal Neurons of Huntington Disease J. Biol. Chem., February 29, 2008; 283(9): 5780 - 5789. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. E. Young, L. Gouw, S. Propp, B. L. Sopher, J. Taylor, A. Lin, E. Hermel, A. Logvinova, S. F. Chen, S. Chen, et al. Proteolytic Cleavage of Ataxin-7 by Caspase-7 Modulates Cellular Toxicity and Transcriptional Dysregulation J. Biol. Chem., October 12, 2007; 282(41): 30150 - 30160. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Jung and N. Bonini CREB-Binding Protein Modulates Repeat Instability in a Drosophila Model for PolyQ Disease Science, March 30, 2007; 315(5820): 1857 - 1859. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. von Mikecz The nuclear ubiquitin-proteasome system J. Cell Sci., May 15, 2006; 119(10): 1977 - 1984. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Arango, S. Holbert, D. Zala, E. Brouillet, J. Pearson, E. Regulier, A. K. Thakur, P. Aebischer, R. Wetzel, N. Deglon, et al. CA150 expression delays striatal cell death in overexpression and knock-in conditions for mutant huntingtin neurotoxicity. J. Neurosci., April 26, 2006; 26(17): 4649 - 4659. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. A. Bates, M. Victor, A. K. Jones, Y. Shi, and A. C. Hart Differential contributions of Caenorhabditis elegans histone deacetylases to huntingtin polyglutamine toxicity. J. Neurosci., March 8, 2006; 26(10): 2830 - 2838. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Matsumoto, S. Kim, and R. I. Morimoto Huntingtin and Mutant SOD1 Form Aggregate Structures with Distinct Molecular Properties in Human Cells J. Biol. Chem., February 17, 2006; 281(7): 4477 - 4485. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Zordan, P. Cisotto, C. Benna, A. Agostino, G. Rizzo, A. Piccin, M. Pegoraro, F. Sandrelli, G. Perini, G. Tognon, et al. Post-transcriptional Silencing and Functional Characterization of the Drosophila melanogaster Homolog of Human Surf1 Genetics, January 1, 2006; 172(1): 229 - 241. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Szatmari, A. Habas, P. Yang, J.-J. Zheng, T. Hagg, and M. Hetman A Positive Feedback Loop between Glycogen Synthase Kinase 3{beta} and Protein Phosphatase 1 after Stimulation of NR2B NMDA Receptors in Forebrain Neurons J. Biol. Chem., November 11, 2005; 280(45): 37526 - 37535. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Matsumoto, A. Stojanovic, C. I. Holmberg, S. Kim, and R. I. Morimoto Structural properties and neuronal toxicity of amyotrophic lateral sclerosis-associated Cu/Zn superoxide dismutase 1 aggregates J. Cell Biol., October 10, 2005; 171(1): 75 - 85. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. M. Kitsos, U. Sankar, M. Illario, J. M. Colomer-Font, A. W. Duncan, T. J. Ribar, T. Reya, and A. R. Means Calmodulin-dependent Protein Kinase IV Regulates Hematopoietic Stem Cell Maintenance J. Biol. Chem., September 30, 2005; 280(39): 33101 - 33108. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Charvin, P. Vanhoutte, C. Pages, E. Borrelli, and J. Caboche Unraveling a role for dopamine in Huntington's disease: The dual role of reactive oxygen species and D2 receptor stimulation PNAS, August 23, 2005; 102(34): 12218 - 12223. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Nguyen, A. Hamby, and S. M. Massa Clioquinol down-regulates mutant huntingtin expression in vitro and mitigates pathology in a Huntington's disease mouse model PNAS, August 16, 2005; 102(33): 11840 - 11845. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Iijima-Ando, P. Wu, E. A. Drier, K. Iijima, and J. C. P. Yin cAMP-response element-binding protein and heat-shock protein 70 additively suppress polyglutamine-mediated toxicity in Drosophila PNAS, July 19, 2005; 102(29): 10261 - 10266. [Abstract] [Full Text] [PDF] |
||||
![]() |
M.-C. Chiang, Y.-C. Lee, C.-L. Huang, and Y. Chern cAMP-response Element-binding Protein Contributes to Suppression of the A2A Adenosine Receptor Promoter by Mutant Huntingtin with Expanded Polyglutamine Residues J. Biol. Chem., April 8, 2005; 280(14): 14331 - 14340. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Poirier, H. Jiang, and C. A. Ross A structure-based analysis of huntingtin mutant polyglutamine aggregation and toxicity: evidence for a compact beta-sheet structure Hum. Mol. Genet., March 15, 2005; 14(6): 765 - 774. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Huang, J. Li, L. Lu, M. Xu, J. Xiao, L. Yin, H. Zhu, Z. Zhou, and J. Sha Novel Development-Related Alternative Splices in Human Testis Identified by cDNA Microarrays J Androl, March 1, 2005; 26(2): 189 - 196. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. M. Everett and N. W. Wood Trinucleotide repeats and neurodegenerative disease Brain, November 1, 2004; 127(11): 2385 - 2405. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. M. Zainelli, C. A. Ross, J. C. Troncoso, J. K. Fitzgerald, and N. A. Muma Calmodulin Regulates Transglutaminase 2 Cross-Linking of Huntingtin J. Neurosci., February 25, 2004; 24(8): 1954 - 1961. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Rustin, D. Bonnet, A. Rotig, A. Munnich, D. Sidi, C. Mariotti, F. Taroni, S. Di Donato, A. Filla, and A. J. Moss Idebenone treatment in Friedreich patients: One-year-long randomized placebo-controlled trial Neurology, February 10, 2004; 62(3): 524 - 525. [Full Text] [PDF] |
||||
![]() |
K. L. Sugars, R. Brown, L. J. Cook, J. Swartz, and D. C. Rubinsztein Decreased cAMP Response Element-mediated Transcription: AN EARLY EVENT IN EXON 1 AND FULL-LENGTH CELL MODELS OF HUNTINGTON'S DISEASE THAT CONTRIBUTES TO POLYGLUTAMINE PATHOGENESIS J. Biol. Chem., February 6, 2004; 279(6): 4988 - 4999. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Obrietan and K. R. Hoyt CRE-Mediated Transcription Is Increased in Huntington's Disease Transgenic Mice J. Neurosci., January 28, 2004; 24(4): 791 - 796. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Rougeulle, P. Navarro, and P. Avner Promoter-restricted H3 Lys 4 di-methylation is an epigenetic mark for monoallelic expression Hum. Mol. Genet., December 15, 2003; 12(24): 3343 - 3348. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. S. Yang and K. L. Burnstein Vitamin D Inhibits G1 to S Progression in LNCaP Prostate Cancer Cells through p27Kip1 Stabilization and Cdk2 Mislocalization to the Cytoplasm J. Biol. Chem., November 21, 2003; 278(47): 46862 - 46868. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Okamura-Oho, T. Miyashita, K. Nagao, S. Shima, Y. Ogata, T. Katada, H. Nishina, and M. Yamada Dentatorubral-pallidoluysian atrophy protein is phosphorylated by c-Jun NH2-terminal kinase Hum. Mol. Genet., July 1, 2003; 12(13): 1535 - 1542. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. P. Taylor, A. A. Taye, C. Campbell, P. Kazemi-Esfarjani, K. H. Fischbeck, and K.-T. Min Aberrant histone acetylation, altered transcription, and retinal degeneration in a Drosophila model of polyglutamine disease are rescued by CREB-binding protein Genes & Dev., June 15, 2003; 17(12): 1463 - 1468. [Abstract] [Full Text] [PDF] |
||||
![]() |
W.-L. Di, J. Monypenny, J. E.A. Common, C. T.C. Kennedy, K. A. Holland, I. M. Leigh, E. L. Rugg, D. Zicha, and D. P. Kelsell Defective trafficking and cell death is characteristic of skin disease-associated connexin 31 mutations Hum. Mol. Genet., August 15, 2002; 11(17): 2005 - 2014. [Abstract] [Full Text] [PDF] |
||||












